» Authors » Melanie Greenland

Melanie Greenland

Explore the profile of Melanie Greenland including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 1947
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakabembe E, Greenland M, Amaral K, Abu-Raya B, Amone A, Andrews N, et al.
Lancet Glob Health . 2024 Dec; 13(1):e81-e97. PMID: 39706666
Background: Immunisation in pregnancy against pertussis can reduce severe disease in infancy. There are few data on the safety and immunogenicity of vaccines given to pregnant women living with HIV...
2.
Kumar M, Little J, Pearce S, MacDonald B, Greenland M, Tarca A, et al.
J Paediatr Child Health . 2024 Jul; 60(8):375-383. PMID: 39051449
Aim: To describe the clinical profile of acute rheumatic fever (ARF) presentations to paediatric cardiology tertiary services in Western Australia (WA). Methods: A retrospective clinical audit of individuals with confirmed...
3.
Murray J, Martins R, Greenland M, Cruz S, Altafim E, Arteche A, et al.
Prev Sci . 2024 Jul; 25(5):834-848. PMID: 38954125
Violence is a major public health problem globally, with the highest rates in low- and middle-income countries (LMICs) in the Americas and southern Africa. Parenting programmes in high-income countries can...
4.
Nedkoff L, Greenland M, Hyun K, Htun J, Redfern J, Stiles S, et al.
Heart Lung Circ . 2024 Feb; 33(3):332-341. PMID: 38326135
Background: Adults <55 years of age comprise a quarter of all acute coronary syndromes (ACS) hospitalisations. There is a paucity of data characterising this group, particularly sex differences. This study...
5.
Kelly E, Greenland M, de Whalley P, Aley P, Plested E, Singh N, et al.
J Infect . 2023 Jun; 87(3):230-241. PMID: 37331429
Background: This was the first study to investigate the reactogenicity and immunogenicity of heterologous or fractional second dose COVID-19 vaccine regimens in adolescents. Methods: A phase II, single-blind, multi-centre, randomised-controlled...
6.
McCann N, Emary K, Singh N, McLean F, Camara S, Jones E, et al.
BMJ Open . 2023 May; 13(5):e068966. PMID: 37225278
Introduction: This is the first efficacy study of an oral live attenuated vaccine against Paratyphi A using a human challenge model of paratyphoid infection. . Paratyphi A is responsible for...
7.
Shaw R, Greenland M, Stuart A, Aley P, Andrews N, Cameron J, et al.
J Infect . 2023 Apr; 86(6):574-583. PMID: 37028454
Background: Heterologous COVID vaccine priming schedules are immunogenic and effective. This report aims to understand the persistence of immune response to the viral vectored, mRNA and protein-based COVID-19 vaccine platforms...
8.
Chappell L, Brocklehurst P, Green M, Hardy P, Hunter R, Beardmore-Gray A, et al.
Health Technol Assess . 2022 Dec; PMID: 36547875
Background: In women with late preterm pre-eclampsia (i.e. at 34 to 36 weeks' gestation), the optimal delivery time is unclear because limitation of maternal-fetal disease progression needs to be balanced...
9.
Stuart A, Virta M, Williams K, Seppa I, Hartvickson R, Greenland M, et al.
J Infect Dis . 2022 Oct; 227(1):71-82. PMID: 36259542
Background: Respiratory syncytial virus (RSV) remains a leading cause of pediatric morbidity, with no approved vaccine. We assessed the safety and immunogenicity of the Ad26.RSV.preF vaccine candidate in adults and...
10.
van der Veere P, Hammami I, Buck G, Greenland M, Offer A, Nunn M, et al.
Alzheimers Dement (Amst) . 2022 Sep; 14(1):e12352. PMID: 36092692
Introduction: Populations at increased risk of dementia need to be identified for well-powered trials of preventive interventions. Weight loss, which often occurs in pre-clinical dementia, could identify a population at...